Daryl S. Schiller

602 total citations
16 papers, 470 citations indexed

About

Daryl S. Schiller is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Daryl S. Schiller has authored 16 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Daryl S. Schiller's work include HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Daryl S. Schiller is often cited by papers focused on HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). Daryl S. Schiller collaborates with scholars based in United States and France. Daryl S. Schiller's co-authors include Jennifer Lê, James Μ. Binley, Arlene Hurley, John P. Moore, Martin Markowitz, Susan J. Little, Douglas D. Richman, Alexandra Trkola, Tom Ketas and Douglas F. Nixon and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Clinical Therapeutics.

In The Last Decade

Daryl S. Schiller

15 papers receiving 457 citations

Peers

Countries citing papers authored by Daryl S. Schiller

Since Specialization

Citations

This map shows the geographic impact of Daryl S. Schiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daryl S. Schiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daryl S. Schiller more than expected).

Fields of papers citing papers by Daryl S. Schiller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daryl S. Schiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daryl S. Schiller. The network helps show where Daryl S. Schiller may publish in the future.

Co-authorship network of co-authors of Daryl S. Schiller

This figure shows the co-authorship network connecting the top 25 collaborators of Daryl S. Schiller. A scholar is included among the top collaborators of Daryl S. Schiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daryl S. Schiller. Daryl S. Schiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Navigating the Shift: Comparing Safety and Cost of Tenecteplase versus Alteplase in Acute Ischemic Stroke 2025 ·The Neurohospitalist ·(unknown), Daryl S. Schiller, (unknown)	1
2	Impact of hydroxychloroquine on disease progression and ICU admissions in patients with SARS-CoV-2 infection 2021 ·American Journal of Health-System Pharmacy ·(unknown), Daryl S. Schiller, (unknown), (unknown)	6
3	Long-Term Efficacy of Oral Vancomycin Prophylaxis for the Prevention of Clostridium difficile Recurrence 2019 ·Journal of Pharmacy Practice ·(unknown), Daryl S. Schiller, (unknown), (unknown)	18
4	Opioid Use in Knee Arthroplasty After Receiving Intravenous Acetaminophen 2014 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), (unknown), (unknown), Daryl S. Schiller, (unknown)	32
5	Evaluation of Bleeding Rates in Renal Transplant Patients on Therapeutic Intravenous Heparin 2013 ·Hospital Pharmacy ·(unknown), (unknown), (unknown), (unknown), Daryl S. Schiller	4
6	Identification, Pharmacologic Considerations, and Management of Prostatitis 2011 ·The American journal of geriatric pharmacotherapy ·Daryl S. Schiller, Ashish Parikh	9
7	Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria 2010 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Jennifer Lê, Elizabeth Dodds Ashley, Melinda M. Neuhauser, Jack Brown, Chris A. Gentry, Michael E. Klepser, Ann Marie Marr, Daryl S. Schiller, (unknown), (unknown), Heather L. VandenBussche, G. Christopher Wood, (unknown)	69
8	Aerosolized Delivery of Antifungal Agents 2010 ·Current Fungal Infection Reports ·Jennifer Lê, Daryl S. Schiller	30
9	Etravirine: A second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV 2009 ·Clinical Therapeutics ·Daryl S. Schiller, (unknown)	38
10	Making the most of your residency 2008 ·American Journal of Health-System Pharmacy ·(unknown), (unknown), (unknown), Marwa Khalifa, Daryl S. Schiller	0
11	Pharmacokinetic and Pharmacodynamic Interactions with Levofloxacin in Renal Transplant Patients with Suspected Pneumonia 2008 ·A. Scott Mathis, Daryl S. Schiller	1
12	Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review 2006 ·Clinical Therapeutics ·(unknown), Daryl S. Schiller	61
13	Identification, management, and prevention of adverse effects associated with highly active antiretroviral therapy 2004 ·American Journal of Health-System Pharmacy ·Daryl S. Schiller	25
14	Safety and Immunogenicity of ALVAC vCP1452 and Recombinant gp160 in Newly Human Immunodeficiency Virus Type 1-Infected Patients Treated with Prolonged Highly Active Antiretroviral Therapy 2002 ·Journal of Virology ·Xia Jin, Murugappan Ramanathan, (unknown), Georges Deschênes, Lei Ba, James Μ. Binley, Daryl S. Schiller, Daniel Bauer, (unknown), Arlene Hurley, L. Gebuhrer, Raphaëlle El Habib, Pierre Caudrelier, Michel Klein, Linqi Zhang, David D. Ho, Martin Markowitz	71
15	The Effect of Highly Active Antiretroviral Therapy on Binding and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Infection 2000 ·The Journal of Infectious Diseases ·James Μ. Binley, Alexandra Trkola, Tom Ketas, Daryl S. Schiller, (unknown), Susan J. Little, Douglas D. Richman, Arlene Hurley, Martin Markowitz, John P. Moore	65
16	The Relationship between T Cell Proliferative Responses and Plasma Viremia during Treatment of Human Immunodeficiency Virus Type 1 Infection with Combination Antiretroviral Therapy 2000 ·The Journal of Infectious Diseases ·James Μ. Binley, Daryl S. Schiller, Gabriel M. Ortiz, Arlene Hurley, Douglas F. Nixon, Martin Markowitz, John P. Moore	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact